![2024 New EU-5 Pricing Strategies: What you need to know about confidential discounts and net prices in EU-5](https://jstindt.com/wp-content/uploads/2024/09/2024-List-Net-Pricing-Strategies-EU-5.jpg)
2024 List and Net Pricing Strategies EU-5
What you need to know about confidential discounts and net prices in EU-5 In the
What you need to know about confidential discounts and net prices in EU-5 In the
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part
The Inflation Reduction Act (IRA), signed into law in August 2022, is a piece of
France’s Reimbursed Early Access Programs (EAP) allow for reimbursement of new drugs and medicines before
The updated regulations are effective immediately upon their publication in Italy’s Official Journal. The new
The Joint Clinical Assessment (JCA) process in the European Union marks a significant advancement in
Justin Stindt Consultants is a fast growing consulting company offering strategy & market access consulting services to leading pharmaceutical, biotech and medical device clients. We operate in Europe and the United States.
© 2024 Justin Stindt Consultants a Brand of Justin Stindt Consulting